LeishMANIAdb
  • Home
  • Browse
  • Manual
  • FAQ
  • Download

Putative tRNA pseudouridine synthase A

Quick info Localization Expansion Sequence features Structure Function Putative motif mimicry Homologs Download

Quick info

Protein:
Putative tRNA pseudouridine synthase A
Gene product:
tRNA pseudouridine synthase A, putative
Species:
Leishmania major
UniProt:
Q4Q1Q8_LEIMA
TriTrypDb:
LmjF.36.1660 * , LMJLV39_360023100 * , LMJSD75_360022900 *
Length:
694

Localization

Secreted promastigote
Source Evidence on protein Close homologs
Cuervo et al. no yes: 0
Hassani et al. no yes: 0
Forrest at al. (metacyclic) no yes: 0
Forrest at al. (procyclic) no yes: 0
Silverman et al. no yes: 0
Pissara et al. no yes: 0
Secreted amastigote
Source Evidence on protein Close homologs
Pires et al. no yes: 0
Exosome
Source Evidence on protein Close homologs
Silverman et al. no yes: 0
Glycosome
Source Evidence on protein Close homologs
Jamdhade et al. no yes: 0
Predictions
Source Evidence on protein Close homologs
DeepLoc
SignalP6 no yes: 0, no: 11
NetGPI no yes: 0, no: 11
Could not find GO cellular_component term for this entry.

Expansion

Sequence features

Q4Q1Q8
Sequence
MSA
Disorder
Secondary
Topology
Domains
SignalP
GPI
Phosphorylations
ELMs

Structure

Predicted structure by AlphaFold2

Related structures:

AlphaFold database: Q4Q1Q8

Function

Biological processes
Term Name Level Count
GO:0006139 nucleobase-containing compound metabolic process 3 7
GO:0006364 rRNA processing 8 3
GO:0006396 RNA processing 6 3
GO:0006725 cellular aromatic compound metabolic process 3 7
GO:0006807 nitrogen compound metabolic process 2 7
GO:0008152 metabolic process 1 7
GO:0009987 cellular process 1 7
GO:0016070 RNA metabolic process 5 7
GO:0016072 rRNA metabolic process 7 3
GO:0034470 ncRNA processing 7 3
GO:0034641 cellular nitrogen compound metabolic process 3 7
GO:0034660 ncRNA metabolic process 6 3
GO:0043170 macromolecule metabolic process 3 7
GO:0044237 cellular metabolic process 2 7
GO:0044238 primary metabolic process 2 7
GO:0046483 heterocycle metabolic process 3 7
GO:0071704 organic substance metabolic process 2 7
GO:0090304 nucleic acid metabolic process 4 7
GO:1901360 organic cyclic compound metabolic process 3 7
GO:0001522 pseudouridine synthesis 6 4
GO:0009451 RNA modification 5 4
GO:0043412 macromolecule modification 4 4
Molecular functions
Term Name Level Count
GO:0003676 nucleic acid binding 3 12
GO:0003723 RNA binding 4 12
GO:0003824 catalytic activity 1 12
GO:0004730 pseudouridylate synthase activity 5 8
GO:0005488 binding 1 12
GO:0009982 pseudouridine synthase activity 4 12
GO:0016829 lyase activity 2 8
GO:0016835 carbon-oxygen lyase activity 3 8
GO:0016836 hydro-lyase activity 4 8
GO:0016853 isomerase activity 2 12
GO:0016866 intramolecular transferase activity 3 12
GO:0097159 organic cyclic compound binding 2 12
GO:1901363 heterocyclic compound binding 2 12
GO:0106029 tRNA pseudouridine synthase activity 5 1
GO:0140098 catalytic activity, acting on RNA 3 1
GO:0140101 catalytic activity, acting on a tRNA 4 1
GO:0140640 catalytic activity, acting on a nucleic acid 2 1

Putative motif mimicry

Leishmania From To Domain/Motif Score
CLV_C14_Caspase3-7 131 135 PF00656 0.661
CLV_C14_Caspase3-7 604 608 PF00656 0.451
CLV_C14_Caspase3-7 613 617 PF00656 0.416
CLV_NRD_NRD_1 108 110 PF00675 0.722
CLV_NRD_NRD_1 214 216 PF00675 0.762
CLV_NRD_NRD_1 255 257 PF00675 0.769
CLV_NRD_NRD_1 297 299 PF00675 0.641
CLV_NRD_NRD_1 308 310 PF00675 0.669
CLV_NRD_NRD_1 31 33 PF00675 0.586
CLV_NRD_NRD_1 346 348 PF00675 0.257
CLV_NRD_NRD_1 48 50 PF00675 0.722
CLV_NRD_NRD_1 56 58 PF00675 0.634
CLV_NRD_NRD_1 582 584 PF00675 0.408
CLV_NRD_NRD_1 590 592 PF00675 0.427
CLV_NRD_NRD_1 637 639 PF00675 0.558
CLV_NRD_NRD_1 659 661 PF00675 0.643
CLV_PCSK_FUR_1 29 33 PF00082 0.604
CLV_PCSK_FUR_1 54 58 PF00082 0.673
CLV_PCSK_FUR_1 588 592 PF00082 0.432
CLV_PCSK_KEX2_1 108 110 PF00082 0.722
CLV_PCSK_KEX2_1 255 257 PF00082 0.769
CLV_PCSK_KEX2_1 297 299 PF00082 0.648
CLV_PCSK_KEX2_1 308 310 PF00082 0.669
CLV_PCSK_KEX2_1 31 33 PF00082 0.577
CLV_PCSK_KEX2_1 346 348 PF00082 0.257
CLV_PCSK_KEX2_1 50 52 PF00082 0.696
CLV_PCSK_KEX2_1 56 58 PF00082 0.595
CLV_PCSK_KEX2_1 582 584 PF00082 0.408
CLV_PCSK_KEX2_1 590 592 PF00082 0.427
CLV_PCSK_KEX2_1 637 639 PF00082 0.554
CLV_PCSK_KEX2_1 659 661 PF00082 0.643
CLV_PCSK_PC1ET2_1 50 52 PF00082 0.732
CLV_PCSK_PC7_1 251 257 PF00082 0.616
CLV_PCSK_SKI1_1 114 118 PF00082 0.539
CLV_PCSK_SKI1_1 202 206 PF00082 0.710
CLV_PCSK_SKI1_1 242 246 PF00082 0.777
CLV_PCSK_SKI1_1 261 265 PF00082 0.628
CLV_PCSK_SKI1_1 470 474 PF00082 0.516
CLV_PCSK_SKI1_1 554 558 PF00082 0.403
CLV_PCSK_SKI1_1 596 600 PF00082 0.454
CLV_PCSK_SKI1_1 615 619 PF00082 0.334
DEG_APCC_DBOX_1 152 160 PF00400 0.609
DEG_APCC_DBOX_1 462 470 PF00400 0.507
DOC_CKS1_1 207 212 PF01111 0.692
DOC_CKS1_1 45 50 PF01111 0.683
DOC_MAPK_DCC_7 386 396 PF00069 0.393
DOC_MAPK_gen_1 108 115 PF00069 0.739
DOC_MAPK_gen_1 505 514 PF00069 0.456
DOC_MAPK_gen_1 659 667 PF00069 0.540
DOC_MAPK_MEF2A_6 388 396 PF00069 0.389
DOC_MAPK_MEF2A_6 505 514 PF00069 0.405
DOC_MIT_MIM_1 150 160 PF04212 0.476
DOC_PP1_RVXF_1 326 332 PF00149 0.390
DOC_PP1_RVXF_1 384 390 PF00149 0.413
DOC_PP1_RVXF_1 535 541 PF00149 0.377
DOC_PP2B_LxvP_1 647 650 PF13499 0.628
DOC_PP4_FxxP_1 389 392 PF00568 0.398
DOC_PP4_FxxP_1 499 502 PF00568 0.464
DOC_USP7_MATH_1 116 120 PF00917 0.597
DOC_USP7_MATH_1 224 228 PF00917 0.672
DOC_USP7_MATH_1 288 292 PF00917 0.553
DOC_USP7_MATH_1 319 323 PF00917 0.677
DOC_USP7_MATH_1 430 434 PF00917 0.457
DOC_USP7_MATH_1 503 507 PF00917 0.480
DOC_USP7_MATH_1 549 553 PF00917 0.410
DOC_USP7_MATH_1 654 658 PF00917 0.694
DOC_USP7_MATH_1 84 88 PF00917 0.754
DOC_WW_Pin1_4 141 146 PF00397 0.532
DOC_WW_Pin1_4 206 211 PF00397 0.704
DOC_WW_Pin1_4 266 271 PF00397 0.686
DOC_WW_Pin1_4 44 49 PF00397 0.685
DOC_WW_Pin1_4 596 601 PF00397 0.459
DOC_WW_Pin1_4 93 98 PF00397 0.626
LIG_14-3-3_CanoR_1 114 123 PF00244 0.533
LIG_14-3-3_CanoR_1 202 207 PF00244 0.635
LIG_14-3-3_CanoR_1 223 233 PF00244 0.569
LIG_14-3-3_CanoR_1 308 313 PF00244 0.638
LIG_14-3-3_CanoR_1 507 511 PF00244 0.416
LIG_14-3-3_CanoR_1 537 541 PF00244 0.363
LIG_14-3-3_CanoR_1 659 663 PF00244 0.640
LIG_Actin_WH2_2 144 162 PF00022 0.559
LIG_Actin_WH2_2 621 639 PF00022 0.589
LIG_BRCT_BRCA1_1 168 172 PF00533 0.684
LIG_deltaCOP1_diTrp_1 575 581 PF00928 0.407
LIG_EH_1 366 370 PF12763 0.457
LIG_FHA_1 147 153 PF00498 0.486
LIG_FHA_1 35 41 PF00498 0.609
LIG_FHA_1 462 468 PF00498 0.468
LIG_FHA_1 481 487 PF00498 0.423
LIG_FHA_2 226 232 PF00498 0.633
LIG_FHA_2 34 40 PF00498 0.598
LIG_FHA_2 597 603 PF00498 0.448
LIG_FHA_2 608 614 PF00498 0.425
LIG_Integrin_isoDGR_2 489 491 PF01839 0.599
LIG_Integrin_RGD_1 132 134 PF01839 0.739
LIG_LIR_Apic_2 497 502 PF02991 0.447
LIG_LIR_Gen_1 610 618 PF02991 0.437
LIG_LIR_Nem_3 539 543 PF02991 0.383
LIG_LIR_Nem_3 575 581 PF02991 0.413
LIG_LIR_Nem_3 610 614 PF02991 0.490
LIG_PCNA_PIPBox_1 1 10 PF02747 0.526
LIG_PTB_Apo_2 492 499 PF02174 0.463
LIG_PTB_Apo_2 605 612 PF02174 0.486
LIG_PTB_Phospho_1 605 611 PF10480 0.483
LIG_RPA_C_Fungi 342 354 PF08784 0.435
LIG_SH2_CRK 397 401 PF00017 0.301
LIG_SH2_SRC 611 614 PF00017 0.501
LIG_SH2_STAP1 508 512 PF00017 0.488
LIG_SH2_STAP1 562 566 PF00017 0.526
LIG_SH2_STAT5 465 468 PF00017 0.294
LIG_SH2_STAT5 580 583 PF00017 0.520
LIG_SH2_STAT5 609 612 PF00017 0.585
LIG_SH2_STAT5 7 10 PF00017 0.662
LIG_SH3_3 553 559 PF00018 0.397
LIG_SH3_3 566 572 PF00018 0.393
LIG_SUMO_SIM_par_1 440 445 PF11976 0.301
LIG_TRAF2_1 181 184 PF00917 0.567
LIG_TRAF2_1 24 27 PF00917 0.591
LIG_TRAF2_1 610 613 PF00917 0.467
LIG_TRAF2_2 145 150 PF00917 0.515
LIG_UBA3_1 156 163 PF00899 0.472
LIG_WRC_WIRS_1 61 66 PF05994 0.690
LIG_WW_1 559 562 PF00397 0.415
LIG_WW_3 390 394 PF00397 0.397
MOD_CDC14_SPxK_1 269 272 PF00782 0.504
MOD_CDK_SPK_2 44 49 PF00069 0.518
MOD_CDK_SPK_2 596 601 PF00069 0.459
MOD_CDK_SPxK_1 266 272 PF00069 0.511
MOD_CDK_SPxK_1 44 50 PF00069 0.682
MOD_CDK_SPxxK_3 44 51 PF00069 0.684
MOD_CK1_1 506 512 PF00069 0.402
MOD_CK2_1 33 39 PF00069 0.715
MOD_CK2_1 342 348 PF00069 0.301
MOD_CK2_1 549 555 PF00069 0.416
MOD_CK2_1 596 602 PF00069 0.445
MOD_CK2_1 607 613 PF00069 0.435
MOD_Cter_Amidation 306 309 PF01082 0.594
MOD_GlcNHglycan 18 21 PF01048 0.675
MOD_GlcNHglycan 280 283 PF01048 0.605
MOD_GlcNHglycan 321 324 PF01048 0.636
MOD_GlcNHglycan 354 357 PF01048 0.312
MOD_GlcNHglycan 58 61 PF01048 0.655
MOD_GlcNHglycan 81 84 PF01048 0.646
MOD_GlcNHglycan 86 89 PF01048 0.660
MOD_GSK3_1 18 25 PF00069 0.527
MOD_GSK3_1 202 209 PF00069 0.703
MOD_GSK3_1 308 315 PF00069 0.691
MOD_GSK3_1 403 410 PF00069 0.272
MOD_GSK3_1 56 63 PF00069 0.668
MOD_GSK3_1 654 661 PF00069 0.697
MOD_LATS_1 14 20 PF00433 0.462
MOD_N-GLC_1 361 366 PF02516 0.362
MOD_N-GLC_1 607 612 PF02516 0.493
MOD_NEK2_1 100 105 PF00069 0.600
MOD_NEK2_1 334 339 PF00069 0.440
MOD_NEK2_1 543 548 PF00069 0.413
MOD_NEK2_2 288 293 PF00069 0.613
MOD_NEK2_2 549 554 PF00069 0.414
MOD_NEK2_2 60 65 PF00069 0.657
MOD_NEK2_2 654 659 PF00069 0.697
MOD_PIKK_1 560 566 PF00454 0.534
MOD_PK_1 308 314 PF00069 0.628
MOD_PKA_1 308 314 PF00069 0.710
MOD_PKA_1 56 62 PF00069 0.682
MOD_PKA_2 308 314 PF00069 0.609
MOD_PKA_2 506 512 PF00069 0.400
MOD_PKA_2 536 542 PF00069 0.368
MOD_PKA_2 56 62 PF00069 0.716
MOD_PKA_2 584 590 PF00069 0.408
MOD_PKA_2 658 664 PF00069 0.717
MOD_PKB_1 54 62 PF00069 0.678
MOD_Plk_1 124 130 PF00069 0.699
MOD_Plk_1 283 289 PF00069 0.762
MOD_Plk_1 448 454 PF00069 0.319
MOD_Plk_1 554 560 PF00069 0.405
MOD_Plk_1 607 613 PF00069 0.486
MOD_Plk_1 688 694 PF00069 0.578
MOD_Plk_2-3 607 613 PF00069 0.451
MOD_Plk_4 168 174 PF00069 0.559
MOD_Plk_4 308 314 PF00069 0.706
MOD_Plk_4 456 462 PF00069 0.326
MOD_Plk_4 60 66 PF00069 0.579
MOD_ProDKin_1 141 147 PF00069 0.528
MOD_ProDKin_1 206 212 PF00069 0.703
MOD_ProDKin_1 266 272 PF00069 0.686
MOD_ProDKin_1 44 50 PF00069 0.682
MOD_ProDKin_1 596 602 PF00069 0.452
MOD_ProDKin_1 93 99 PF00069 0.627
MOD_SUMO_for_1 234 237 PF00179 0.663
MOD_SUMO_rev_2 154 161 PF00179 0.437
MOD_SUMO_rev_2 236 244 PF00179 0.635
MOD_SUMO_rev_2 607 617 PF00179 0.439
TRG_DiLeu_BaEn_1 241 246 PF01217 0.678
TRG_DiLeu_BaEn_2 326 332 PF01217 0.524
TRG_DiLeu_BaEn_2 448 454 PF01217 0.361
TRG_DiLeu_BaEn_2 687 693 PF01217 0.487
TRG_DiLeu_BaEn_4 183 189 PF01217 0.585
TRG_ENDOCYTIC_2 138 141 PF00928 0.713
TRG_ENDOCYTIC_2 611 614 PF00928 0.575
TRG_ER_diArg_1 177 180 PF00400 0.515
TRG_ER_diArg_1 29 32 PF00400 0.632
TRG_ER_diArg_1 296 298 PF00400 0.654
TRG_ER_diArg_1 386 389 PF00400 0.400
TRG_ER_diArg_1 467 470 PF00400 0.317
TRG_ER_diArg_1 48 51 PF00400 0.721
TRG_ER_diArg_1 581 583 PF00400 0.413
TRG_ER_diArg_1 588 591 PF00400 0.433
TRG_ER_diArg_1 636 638 PF00400 0.602
TRG_Pf-PMV_PEXEL_1 261 265 PF00026 0.716
TRG_Pf-PMV_PEXEL_1 421 426 PF00026 0.317
TRG_Pf-PMV_PEXEL_1 601 605 PF00026 0.400
TRG_Pf-PMV_PEXEL_1 640 644 PF00026 0.642

Homologs

Protein Taxonomy Sequence identity Coverage
A0A0N1I5W9 Leptomonas seymouri 69% 85%
A0A0S4IST3 Bodo saltans 41% 100%
A0A1X0P7U6 Trypanosomatidae 54% 100%
A0A3R7R867 Trypanosoma rangeli 54% 100%
A0A3S7XAP2 Leishmania donovani 93% 79%
A4HP30 Leishmania braziliensis 84% 100%
A4IDD7 Leishmania infantum 93% 79%
D0A313 Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) 54% 100%
E9AST8 Leishmania mexicana (strain MHOM/GT/2001/U1103) 92% 100%
V5BPI0 Trypanosoma cruzi 56% 100%

Download

Download
LeishMANIAdb - Server version: v0.0.2. - Database version: v0.0.1. - ChangeLog - © 2022-2025 Protein Bioinformatics Research Group, Institute of Enzymology, RCNS